Lincas syrup 120 ml. vial

Description

Lincas syrup Instructions for use
Composition active ingredients: 5 ml of syrup contains: vascular adhatodes (Adhatoda vasica), thick extract leaves (3.25: 1), (extractant water) 92.31 mg of licorice (Glycyrrhiza glabra), thick extract roots (3.25: 1 ) (extractant water) 11.54 mg of long pepper (Piper longum), fruits of thick extract (3.25: 1) (extractant water), 15.38 mg of fragrant violet (Viola odorata), flowers of thick extract (3.25: 1), (extractant water) 3.85 mg of hyssop officinalis (Hyssopus officinalis), flowers of thick extract (3.25: 1) (extractant water), 7.7 mg of large galangal (Alpinia galanga) rhizomes and roots of thick extract (3 , 25: 1) (extractant water) 7.7 mg of cordia latifolia (Cordia latifolia) fruits of thick extract (3.25: 1) (extractant water), 15.38 mg of marshmallow (Althaea officinalis), seeds of thick extract (3 , 25: 1) (extractant water), 15.38 mg of common ziziphus (Zyzyphus vulgaris), fruits of thick extract (3.25: 1) (extractant water), 15.38 mg of bracts onosma (Onosma bracteatum), or thick extract and flowers (3.25: 1) (extractant water) 15.38 mg; excipients: sucrose, anhydrous citric acid, glycerin, methylparaben (E 218), propylparaben (E 216), propylene glycol, peppermint oil, clove oil, purified water.

Lincas syrup Dosage form
Syrup.

Basic physical and chemical properties.

Homogeneous brown syrup with peppermint flavor and specific odor. Sediment formation is allowed.

Pharmacotherapeutic group
Combined drugs used for colds. ATX code R05 X.

Lincas syrup  Pharmacodynamics
A complex preparation based on medicinal herbs with anti-inflammatory, expectorant, mucolytic, antispasmodic and antipyretic properties. Improves the secretory function of the airway epithelium, surface-active properties of the pulmonary surfactant, stimulates the function of the epithelial villi, which has a positive effect on the exudative and polyferative phases of inflammation. Thinns thick mucus and makes it easier for mucus to escape from the respiratory tract. It acts as a local antiseptic on the mucous membranes of the pharynx and bronchi.

Pharmacokinetics
Studies have shown that the use of the drug reduces the tone of the smooth muscles of the bronchioles and trachea, increases the size of the bronchioles and alveolar sacs, reduces swelling of the mucous membranes. Changes in the severity of cough are observed after 3 to 4 days of taking the drug.

Indications
Complex therapy of inflammatory diseases of the upper and lower respiratory tract, accompanied by dry irritating cough; bronchitis (acute and chronic); pharyngitis, tracheitis, tracheobronchitis.

Lincas syrup  Contraindications
Hypersensitivity to the components of the drug, diabetes mellitus.
Organic heart damage (myocarditis, pericarditis, myocardial infarction), arterial hypertension, impaired liver and kidney function; hypokalemia, severe obesity.
Interaction with other medicinal products and other types of interactions
Simultaneous use with antitussives that reduce sputum discharge (such as codeine) is not recommended.

If you need to use any other medicines, you should inform your doctor.

Application features
The syrup contains sugar, which should be considered by people on a low-calorie diet.

The ability to influence the reaction rate when driving or operating machinery
Does not affect the ability to drive or operate machinery.

Use during pregnancy or lactation
With caution and only as directed by a doctor, use the drug during pregnancy and lactation only if the expected benefit to the mother outweighs the potential risk to the fetus / child.

Method of administration and dosage
Take orally.

Adults and children over 12 years of age take 2 teaspoons (10 ml) of syrup 3-4 times a day.

Children aged 7 to 11 years – 1 teaspoon (5 ml) of syrup 4 times a day.

Children aged 3 to 6 years – 1 teaspoon (5 ml) of syrup 3 times a day.

Children aged 1 to 2 years – 1/2 teaspoon (2.5 ml) 3-4 times a day.

The duration of treatment is from 3 to 7 days.

Children
Do not prescribe the drug to children under 1 year of age.

Overdose
Overdose and prolonged use (more than 2 months) can cause a violation of the water-electrolyte balance, as a result of which hypokalemic myopathy and myoglobinuria may develop. Increased side effects are possible.

Accidental overdose has not been reported.

Adverse Reactions
When using the drug, weakness, increased blood pressure, hypokalemia, allergic reactions (including rashes, skin hyperemia, erythema annular, itching, urticaria, angioedema) increased salivation, irritation of the gastric mucosa are possible.

If any adverse reactions occur, you should stop using the drug and consult a doctor.

Shelf life
3 years.